Librax (Chlordiazepoxide and Clidinium) Dosing for Adults
The recommended dosage of Librax (chlordiazepoxide hydrochloride and clidinium bromide) for adults is 1 or 2 capsules, 3 or 4 times a day, administered before meals and at bedtime. 1
Standard Dosing Guidelines
- The usual maintenance dose is 1-2 capsules taken 3-4 times daily, specifically before meals and at bedtime 1
- Dosing should be individualized based on patient response and clinical presentation 1
- The medication combines chlordiazepoxide (a benzodiazepine) with clidinium (an anticholinergic agent) 1, 2
Geriatric Dosing Considerations
- For elderly patients, dosage should be limited to the smallest effective amount to prevent ataxia, oversedation, or confusion 1
- Initial dose for elderly patients should not exceed 2 Librax capsules per day 1
- Dose can be gradually increased as needed and tolerated in geriatric patients 1
- Elderly patients have an increased risk of dose-related adverse reactions 1
Pharmacokinetic Considerations
- Chlordiazepoxide has a complex metabolic pathway with multiple active metabolites (desmethylchlordiazepoxide, demoxepam, desmethyldiazepam, and oxazepam) 2
- The elimination half-life of chlordiazepoxide typically ranges from 5-30 hours in healthy individuals 2
- Clearance of chlordiazepoxide is reduced and half-life is prolonged in elderly patients and those with liver cirrhosis 2, 3
- Multiple-dose therapy results in accumulation of the parent compound and its active metabolites 2
Special Population Considerations
Patients with Hepatic Impairment
- Use caution in patients with hepatic insufficiency as chlordiazepoxide metabolism occurs through hepatic oxidation 3
- Delayed metabolism in hepatic impairment can lead to "dose-stacking" where unmetabolized chlordiazepoxide accumulates 3
- This accumulated reservoir undergoes slow biotransformation to active metabolites even after dosing is discontinued 3
- The metabolite demoxepam has a markedly longer half-life (14-95 hours) than chlordiazepoxide (6.6-28 hours), which may be further prolonged by hepatic insufficiency 3
Discontinuation Protocol
- To reduce withdrawal reactions, use a gradual taper when discontinuing Librax 1
- If withdrawal reactions develop, consider pausing the taper or increasing the dosage to the previous tapered level 1
- Subsequently decrease the dosage more slowly to minimize withdrawal symptoms 1
Important Monitoring Considerations
- Monitor for sedation, particularly when used with other central nervous system depressants 1, 4
- Be aware that standard therapeutic doses of chlordiazepoxide (10 mg three times daily) have not been shown to potentiate the effects of moderate alcohol consumption in studies 4
- Regular assessment for side effects related to both the benzodiazepine component (sedation, ataxia) and anticholinergic component (dry mouth, urinary hesitancy) is recommended 1
Common Pitfalls and Caveats
- Avoid abrupt discontinuation due to risk of withdrawal symptoms 1
- Use caution when prescribing to elderly patients due to increased sensitivity to both benzodiazepine and anticholinergic effects 1
- Be aware of potential for dependence with long-term use of the chlordiazepoxide component 1
- Intramuscular injection of chlordiazepoxide should be avoided as it results in slow and erratic absorption 2